The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Effect of Treatment With Peginterferon or Interferon Alfa–2B and Ribavirin on Steatosis in Patients Infected With Hepatitis C
Abstract
It has been suggested that hepatitis C virus (HCV) and especially genotype 3 is associated with steatosis. We assess the effect of treatment with peginterferon or interferon alfa–2b and ribavirin on steatosis. We analyzed 1,428 naïve patients included in a randomized trial. A single pathologist scored steatosis at baseline and 24 weeks after the treatment. At baseline, steatosis was present in 935 of 1,428 patients (65%), including 175 (83%) of 210 patients with genotype 3 versus 760 (62%) of 1,218 with other genotypes (P < .001). The variables associated with steatosis in logistic regression were genotype 3 (P < .001), triglycerides greater than 1.7 mmol/L (P < .001), body mass index greater than 27 (P < .04), age greater than 40 years (P < .001), and septal fibrosis (P = .007). In genotype 3–infected patients, steatosis was associated with high viral load and with lower serum cholesterol. Steatosis was associated with lower sustained response rate, even after taking into account other factors (P < .001). Among virologic responders, steatosis was much improved in genotype 3, improvement of at least 1 grade in 77%, and disappearance in 46% compared with other genotypes, 46% and 29%, respectively (P < .001 both comparisons). In genotype 3 responders, the baseline low serum cholesterol was corrected by treatment (P < .001). Steatosis was associated with HCV genotype 3, triglycerides, high body mass index, age, fibrosis stage, and lower virologic response to treatment. In conclusion, sustained disappearance of the virus is associated with reduction of steatosis in genotype 3 as well as a correction of baseline low serum cholesterol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Self-citationAn Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Self-citationBedossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,003
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
Number Cruncher Statistical Systems (NCSS)
McKenzie, J. D., & Hintze, J. L. (1985) · The American Statistician · doi:10.2307/2683719 · Cited by 810
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Van Heuverswyn, H., & Maertens, G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-6-1093 · Cited by 685
Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1200 · Cited by 658
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
Rubbia-Brandt, L., Quadri, R., Abid, K., Giostra, E., Malé, P.-J., Mentha, G., Spahr, L., Zarski, J.-P., Borisch, B., Hadengue, A., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80166-x · Cited by 593
Bach, N., Thung, S. N., & Schaffner, F. (1992) · Hepatology · doi:10.1002/hep.1840150403 · Cited by 500
Kumar, D., Farrell, G. C., Fung, C., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.36370 · Cited by 379
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Eslam, M., Sarin, S. K., Wong, V. W.-S., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M.-H., Shiha, G., Yilmaz, Y., Gani, R., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 833
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
McCullough, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.004 · Cited by 580
Leandro, G., Mangia, A., Hui, J., Fabris, P., Rubbia–Brandt, L., Colloredo, G., Adinolfi, L. E., Asselah, T., Jonsson, J. R., Smedile, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.014 · Cited by 565
Beste, L. A., Leipertz, S. L., Green, P. K., Dominitz, J. A., Ross, D., & Ioannou, G. N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.056 · Cited by 459
ZEUZEM, S. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.007 · Cited by 448
Self-citationHonda, M., Sakai, A., Yamashita, T., Nakamoto, Y., Mizukoshi, E., Sakai, Y., Yamashita, T., Nakamura, M., Shirasaki, T., Horimoto, K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.049 · Cited by 400
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?
Asselah, T., Rubbia-Brandt, L., Marcellin, P., & Negro, F. (2006) · Gut · doi:10.1136/gut.2005.069757 · Cited by 395
Steatosis: Co-factor in Other Liver Diseases *
Powell, E. E., Jonsson, J. R., & Clouston, A. D. (2005) · Hepatology · doi:10.1002/hep.20750 · Cited by 374
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
Poynard, T., Ratziu, V., Naveau, S., Thabut, D., Charlotte, F., Messous, D., Capron, D., Abella, A., Massard, J., Ngo, Y., et al. (2005) · Comparative Hepatology · doi:10.1186/1476-5926-4-10 · Cited by 368
Self-citationClouston, A. D., Powell, E. E., Walsh, M. J., Richardson, M. M., Demetris, A. J., & Jonsson, J. R. (2005) · Hepatology · doi:10.1002/hep.20650 · Cited by 361
Poynard, T., Munteanu, M., Imbert-Bismut, F., Charlotte, F., Thabut, D., Le Calvez, S., Messous, D., Thibault, V., Benhamou, Y., Moussalli, J., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032227 · Cited by 343
Self-citationTreatment predictors of a sustained virologic response in hepatitis B and C
Kau, A., Vermehren, J., & Sarrazin, C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.013 · Cited by 324
Koh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
Loria, P., Adinolfi, L. E., Bellentani, S., Bugianesi, E., Grieco, A., Fargion, S., Gasbarrini, A., Loguercio, C., Lonardo, A., Marchesini, G., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.021 · Cited by 294
Histological assessment of non‐alcoholic fatty liver disease
Hübscher, S. G. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02416.x · Cited by 292
Sasso, M., Miette, V., Sandrin, L., & Beaugrand, M. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.08.001 · Cited by 283
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
Karsdal, M. A., Manon-Jensen, T., Genovese, F., Kristensen, J. H., Nielsen, M. J., Sand, J. M. B., Hansen, N.-U. B., Bay-Jensen, A.-C., Bager, C. L., Krag, A., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00447.2014 · Cited by 263
Zeuzem, S. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00033 · Cited by 261
Self-citationWaris, G., Felmlee, D. J., Negro, F., & Siddiqui, A. (2007) · Journal of Virology · doi:10.1128/jvi.00125-07 · Cited by 260
RetractedPoynard, T., McHutchison, J., Manns, M., Myers, R. P., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50319 · Cited by 253
Self-citationAbnormalities of lipid metabolism in hepatitis C virus infection
Negro, F. (2010) · Gut · doi:10.1136/gut.2009.192732 · Cited by 162
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61
Xu, J., Xu, P., Wu, M., Chen, H., Xu, J., Wu, M., Li, M., & Qian, F. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s91748 · Cited by 20
Metadata
- Authors
- Poynard, T., Ratziu, V., McHutchison, J., Manns, M., Goodman, Z., Zeuzem, S., Younossi, Z., & Albrecht, J.
- Venue
- Hepatology
- Published
- 2003-07
- Volume
- 38
- Issue
- 1
- Pages
- 75-85
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2057211436
- Cited by
- 604
- References
- 21
- FWCI
- 27.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.